Delivery Order 75N98019D00061-75N98020F00001
Award Date 2/19/20
Potential Completion Date 2/18/25
Potential Value $2.3M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
North Bethesda, MD 20852, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is a delivery order under the Drug Manufacturing and Formulation Program (DMFP) Indefinite Delivery Contract (IDC) awarded to MRI GLOBAL, also known as Midwest Research Institute. The purpose is to de-obligate unexpended and expiring fiscal year 2020 funding in preparation for the closing of the period of availability for these funds. The prime contractor, MRI GLOBAL, is a 501(c)(3) not-for-profit research organization based in Kansas City, Missouri that provides...
- This is a $5,108,214.00 cost-plus-award-fee delivery order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The contract is part of the Drug Manufacturing and Formulation Program (DMFP) with an ultimate completion date of September 18, 2029. Mriglobal has been awarded multiple significant federal contracts and grants, including Indefinite Delivery Contracts...
- This federal contract award is for the Drug Manufacturing and Formulation Program (DMFP) Task Order #01: Performance Activity, issued by the National Institute on Drug Abuse, a civilian agency. The $515,658.99 cost-plus-fixed-fee contract was awarded on January 15, 2015 to the prime contractor MRIGlobal, doing business as Midwest Research Institute, a 501(c)(3) non-profit organization. The contract involves technical support for the DMFP program and includes de-obligating unexpended and expiring...
- This is a delivery order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke to MRIGlobal, a not-for-profit research organization also known as Midwest Research Institute. The contract is part of the Drug Manufacturing and Formulation Program (DMFP) master IDIQ contract vehicle and has a potential value of $1,535,538.00. The contract does not have a set-aside designation. Under this contract,...
- This is a cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Mriglobal, doing business as Midwest Research Institute, a non-profit research organization. The contract is valued at $949,295.00 and will run through January 31, 2026. The contract is for the evaluation of the shelf-life of samples of investigational clinical drug formulations, including parenteral, oral, and other dosage...
- This is a Cost Plus Award Fee delivery order under a $1,283,149.00 contract awarded by the National Institute of Neurological Disorders and Stroke, a civilian agency, to Mriglobal (also known as Midwest Research Institute), a 501(c)(3) not-for-profit research organization. The contract is part of the Drug Manufacturing and Formulation Program (DMFP) master IDIQ, and the task is for the PADERI HEAL PROJECT-IHP-102. There is no set-aside designation for this award. Mriglobal is the prime...
- This is a $470,254.00 Firm Fixed Price Delivery Order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to The University of Iowa. The contract is part of the NCATS Drug Product Development Studies 2017-2022 Indefinite Delivery Vehicle (IDV) contract, which allows NCATS to issue task orders for specialized research services. This specific task order is for dosage form development, manufacturing, and stability studies of the drug compound...
- This is a delivery order awarded under a $3,500,000 indefinite-delivery, indefinite-quantity (IDIQ) contract with the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The contract is for the Diagnostics Pre-Clinical Services Program and is a firm fixed-price arrangement. The prime contractor is Mriglobal, a 501(c)(3) not-for-profit research organization that provides scientific research, testing, training, and product...
- This is a $99,500.00 delivery order contract awarded to Mriglobal, also doing business as Midwest Research Institute, by the Department of Health and Human Services' National Institutes of Health National Institute on Aging. The contract is for drug toxicity testing services, with a period of performance through July 31, 2024. The contract is not set aside for any small business program. Mriglobal is a 501(c)(3) non-profit research organization that specializes in scientific research, testing,...
- This federal contract award, with an ID of 75N91023D00010|75N91024F00001, was issued by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract, which is not set aside, has a ceiling value of $1,866,116.00 and a completion date of September 17, 2026. The scope of the contract includes the production of a drug substance, conversion of the drug substance to a drug product, filling the drug product into applicators for clinical...